JJIV-home-hero image dec 2022.jpg

Partnering with entrepreneurs
to advance health equity

Photo courtesy of Redbird

An impact fund within the Johnson & Johnson Foundation, we invest in companies and entrepreneurs innovating to improve health equity for underserved patients around the world.

More than half the world's population lacks access to essential health services.

- World Health Organization & World Bank

Watch video: Why we support health impact entrepreneurs

Watch video: Why we support health impact entrepreneurs

J&J Impact Ventures supports a global portfolio of early-stage companies and partners working to accelerate access to affordable and quality healthcare for all. We are fueled by the potential of impact entrepreneurs to create new market-based solutions to address health inequities. Because when social impact is at the core of the business model, if the company is sustainable, then the impact is sustainable.

LEARN MORE ABOUT US

2.8M Patients Reached

There have been 2.8 million lives positively impacted by the healthcare services and products of our portfolio companies, in addition to the millions more reached indirectly through our support of healthcare systems and healthcare professionals.

Joe Wolk.jpg

“While there is a significant challenge of achieving universal health coverage globally, we are inspired by the innovative companies that J&J Impact Ventures is supporting to build sustainable solutions for underserved communities around the world.”

- Joseph Wolk, Chief Financial Officer, Johnson & Johnson; Chair, J&J Impact Ventures Investment Committee

Company Spotlight

SwipeRx is helping millions of patients in Southeast Asia with access to quality and affordable medicines through its innovative digital platform and network reaching over 250,000 pharmacists.

EXPLORE OUR PORTFOLIO

Latest News & Updates

News & Insights

Johnson & Johnson Impact Ventures Invests in Mamotest to Improve Access to Care for Breast Cancer Patients in Latin America

Breast cancer is the most common type of cancer worldwide, but when caught early enough, has a 98% survival rate. Unfortunately, in many countries and rural areas, there are significant challenges with access, awareness, high costs and poor-quality diagnostics—all leading to undiagnosed patients or late-stage detection, where the survival rate can drop to as low as 40%. Even after diagnosis, fragmented and confusing healthcare systems block many patients from getting the treatments and care they need to survive. This is why access to early, high-quality exams and continuity of treatment support are crucial to saving patients’ lives.

2 Min Read

Learn More

News & Insights

Mamotest secures $3.3 million for breast cancer screening in Latin America

The company raised $3.3 million in pre-Series A funding from Johnson & Johnson Impact Ventures, Merck, Sonen Capital and venture capital firm Sky High.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Founders Factory Africa to Build and Scale Healthcare Startups in Africa

Although Africa does not suffer from a lack of entrepreneurial interest, innovation still faces major challenges. In particular, it’s often difficult for founders to get funding and other needed support when their businesses are in early stages of development. Most funding in Africa goes to lower-risk, later-stage companies, and early-stage African entrepreneurs receive only 8% of total investment dollars compared to 20-25% in other startup-supportive economies.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Clinify Health to Support Financial Sustainability of Community Health Centers in the U.S. and to Improve Patient Health Outcomes

Federally Qualified Health Centers (FQHCs) provide comprehensive primary care and ancillary services to almost 90 million patients in the United States. They play a critical role in bridging the gap to reach under-resourced communities and improving their health. However, FQHCs are often reimbursed on a per patient encounter basis, rather than the measures tied to patient’s overall health, engagement and costs. Ultimately, this antiquated reimbursement model encourages quantity over quality, limiting providers’ ability to ensure enough time, resources and management of that patient’s care is closely tied to the medical complexity of the patients themselves.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Penda Health to Expand Access to Primary Healthcare in Kenya

Like many countries in Africa, Kenya has a low doctor-to-patient ratio, and millions of people do not have access to healthcare that is both high-quality and affordable. Penda Health was founded with a mission to bridge the gap between costly private healthcare and overcrowded public facilities, providing a new model for delivering care to families and underserved communities.

1 Min Read

Learn More

News & Insights

Johnson & Johnson Impact Ventures Invests in Certintell Telehealth to Increase the Capacity of Community-Based Health Centers in the U.S.

In the United States, 60% of people have chronic health conditions such as diabetes, heart disease and cancer. Black, Indigenous and Latino Americans are two times as likely to suffer from these conditions. Many of these diverse groups rely on community-based organizations for their care, including nearly 1,500 Federally Qualified Health Centers (FQHCs) serving about 32 million people around the country. However, these health centers also face staffing and capacity issues due to healthcare worker burnout.

1 Min Read

Learn More

JW & DD promo.jpg

News & Insights

From Idea to Investment to Impact: Q&A Between Joe Wolk and Dana Deardorff

Dana Deardorff, Global Director, for Johnson & Johnson Impact Ventures (JJIV), an impact fund within the Johnson & Johnson Foundation, covers JJIV’s investment thesis, trends in the HealthTech space and what entrepreneurs need to succeed in today’s environment with Joe Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson and Investment Committee Chairman for Johnson & Johnson Impact Ventures.

6 Min Read

Learn More

JJIV - VilCap Q&A Banner - March 2023.png

News & Insights

Flipping the Scripts: Village Capital Lets Startups Choose Who Wins Funding

In 2009, Village Capital, the world’s largest organization supporting impact-driven, seed-stage startups, began exploring solutions to a challenge they saw blocking progress toward racial equity in venture capital. They noticed a systemic reliance on “pattern recognition” among most venture capital firms, in which investors—a predominantly White and male population—were more likely to support those that looked like them.

5 Min Read

Learn More

News & Insights

Certintell Telehealth Receives New Funding to Expand Virtual Care Services to More Communities (PRESS RELEASE)

The company plans to support more health providers and patients with chronic conditions

1 Min Read

Learn More

Subscribe to Our Newsletter

First Name

Last Name

Email

Organization

Country (Optional)